These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8886107)

  • 21. Aging and neural control of the GI tract: III. Senescent enteric nervous system: lessons from extraintestinal sites and nonmammalian species.
    Wiley JW
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1020-6. PubMed ID: 12381514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of cell death in experimental models of Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526
    [No Abstract]   [Full Text] [Related]  

  • 23. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
    Anglade P; Vyas S; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jul; 12(3):603-10. PubMed ID: 9225140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The aging nerve cell].
    Hervonen A
    Duodecim; 1990; 106(22):1497-500. PubMed ID: 1364682
    [No Abstract]   [Full Text] [Related]  

  • 25. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.
    Stefanis L; Wang Q; Oo T; Lang-Rollin I; Burke RE; Dauer WT
    Eur J Neurosci; 2004 Oct; 20(7):1969-72. PubMed ID: 15380020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
    Ahn KH; Kim YS; Kim SY; Huh Y; Park C; Jeong JW
    Neurosci Lett; 2009 Jan; 449(2):93-7. PubMed ID: 19000740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
    Kazantsev AG; Kolchinsky AM
    Arch Neurol; 2008 Dec; 65(12):1577-81. PubMed ID: 19064744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
    Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
    J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide and basal ganglia degeneration.
    Rose S; MacKenzie GM; Jenner P
    Adv Neurol; 1999; 80():247-57. PubMed ID: 10410729
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine cell death by a single genetic mechanism: phenotypic analysis and linkage study of autosomal recessive juvenile parkinsonism.
    Matsumine H; Saito M; Ishikawa A; Yokochi M; Yamamura Y; Tsuji S; Mizuno Y
    Adv Neurol; 1999; 80():187-94. PubMed ID: 10410720
    [No Abstract]   [Full Text] [Related]  

  • 33. Human melanocytes as a model system for studies of Alzheimer disease.
    Yaar M; Gilchrest BA
    Arch Dermatol; 1997 Oct; 133(10):1287-91. PubMed ID: 9382568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Watch for ICE in neurodegeneration.
    Vasilakos J; Shivers B
    Mol Psychiatry; 1996 Mar; 1(1):72-6. PubMed ID: 9118318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why hasn't neuroprotection worked in Parkinson's disease?
    Kieburtz K; Ravina B
    Nat Clin Pract Neurol; 2007 May; 3(5):240-1. PubMed ID: 17479072
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
    Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis in the rat basal forebrain during development and following lesions of connections.
    Sophou S; Dori I; Antonopoulos J; Parnavelas JG; Dinopoulos A
    Eur J Neurosci; 2006 Jul; 24(2):573-85. PubMed ID: 16903859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support.
    Ohgoh M; Kimura M; Ogura H; Katayama K; Nishizawa Y
    Exp Neurol; 1998 Jan; 149(1):51-63. PubMed ID: 9454614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biology. miRNAs in neurodegeneration.
    Hébert SS; De Strooper B
    Science; 2007 Aug; 317(5842):1179-80. PubMed ID: 17761871
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular mechanism of monoamine toxicity in Parkinson's disease: hypothetical cell death model.
    Jimenez del Rio M; Velez-Pardo C
    Med Hypotheses; 2000 Feb; 54(2):269-74. PubMed ID: 10790763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.